Genomic signature of trastuzumab neoadjuvant therapy predictive of patient survival in HER2-positive breast cancer

被引：0
|
作者：
Briones, Natalia [1 ]
Facista, Salvatore [1 ]
Halperin, Rebecca [1 ]
Heaton, Paul [2 ]
Mahadevan, Daruka [3 ]
Hendricks, Wiiliam [1 ]
Kim, Suwon [2 ]
机构：
[1] Translat Genom Res Inst, Phoenix, AZ USA
[2] Univ Arizona, Coll Med Phoenix, Phoenix, AZ USA
[3] Univ Arizona, Ctr Canc, Tucson, AZ USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-3412
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3412
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study
    Li, Junjie
    Shao, Zhimin
    Xu, Binghe
    Jiang, Zefei
    Cui, Shude
    Zhang, Jin
    Liao, Ning
    Jiang, Jun
    Wang, Yongsheng
    Ouyang, Quchang
    Ying, Ziwei
    MEDICINE, 2018, 97 (21)
  • [32] Signature-guided biomarker discovery and therapy for trastuzumab-resistant HER2-positive breast cancer
    Yin, J.
    Sand, A.
    Sun, C.
    Piacsek, M.
    Beres, A.
    Tjoe, J. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [33] Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
    Taveira, Mateus de Oliveira
    Nabavi, Sheida
    Wang, Yuker
    Tonellato, Peter
    Esteva, Francisco J.
    Cantley, Lewis C.
    Wulf, Gerburg M.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (07) : 1255 - 1262
  • [34] Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
    Mateus de Oliveira Taveira
    Sheida Nabavi
    Yuker Wang
    Peter Tonellato
    Francisco J. Esteva
    Lewis C. Cantley
    Gerburg M. Wulf
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1255 - 1262
  • [35] Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab
    Ligorio, Francesca
    Di Cosimo, Serena
    Verderio, Paolo
    Ciniselli, Chiara Maura
    Pizzamiglio, Sara
    Castagnoli, Lorenzo
    Dugo, Matteo
    Galbardi, Barbara
    Salgado, Roberto
    Loi, Sherene
    Michiels, Stefan
    Triulzi, Tiziana
    Tagliabue, Elda
    El-Abed, Sarra
    Izquierdo, Miguel
    de Azambuja, Evandro
    Nuciforo, Paolo
    Huober, Jens
    Moscetti, Luca
    Janni, Wolfgang
    Coccia-Portugal, Maria Antonia
    Corsetto, Paola Antonia
    Belfiore, Antonino
    Lorenzini, Daniele
    Daidone, Maria Grazia
    Vingiani, Andrea
    Gianni, Luca
    Pupa, Serenella Maria
    Bianchini, Giampaolo
    Pruneri, Giancarlo
    Vernieri, Claudio
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (12): : 1720 - 1727
  • [36] Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors
    Buzatto, I. P. C.
    Ribeiro-Silva, A.
    Andrade, J. M.
    Carrara, H. H. A.
    Silveira, W. A.
    Tiezzi, D. G.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2017, 50 (02)
  • [37] Trastuzumab as Single Agent Therapy for HER2-Positive Metastatic Breast Cancer
    Rastogi, Priya
    Davidson, Nancy E.
    ONKOLOGIE, 2010, 33 (8-9): : 420 - 421
  • [38] Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients
    Yamshiro, Hiroyasu
    Iwata, Hiroji
    Masuda, Norikazu
    Yamamoto, Naohito
    Nishimura, Reiki
    Ohtani, Shoichiro
    Sato, Nobuki
    Takahashi, Masato
    Kamio, Takako
    Yamazaki, Kosuke
    Saito, Tsuyoshi
    Kato, Makoto
    Lee, Tecchuu
    Ohno, Shinji
    Kuroi, Katsumasa
    Takano, Toshimi
    Takada, Masahiro
    Yasuno, Shinji
    Morita, Satoshi
    Toi, Masakazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 709 - 722
  • [39] Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients
    Hiroyasu Yamshiro
    Hiroji Iwata
    Norikazu Masuda
    Naohito Yamamoto
    Reiki Nishimura
    Shoichiro Ohtani
    Nobuki Sato
    Masato Takahashi
    Takako Kamio
    Kosuke Yamazaki
    Tsuyoshi Saito
    Makoto Kato
    Tecchuu Lee
    Shinji Ohno
    Katsumasa Kuroi
    Toshimi Takano
    Masahiro Takada
    Shinji Yasuno
    Satoshi Morita
    Masakazu Toi
    International Journal of Clinical Oncology, 2015, 20 : 709 - 722
  • [40] Trastuzumab therapy for small, HER2-positive breast tumours
    Nature Reviews Clinical Oncology, 2015, 12 (3) : 126 - 126
12345